Adamas to Announce Third Quarter 2019 Financial Results and Host Conference Call on November 7, 2019
October 30 2019 - 4:30PM
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that
the company will report 2019 third quarter financial results on
Thursday, November 7, 2019, after market close. Subsequently,
Adamas’ management team will host a conference call and webcast at
4:30 p.m. Eastern Time to discuss the financial results and provide
a corporate update.
Investor Conference Call and
Webcast The conference call can be accessed by dialing
(844) 215-3280 for participants in the U.S. or Canada and
(484) 747-6383 for international callers. The webcast can be
accessed live via the investor section of the Adamas website at
ir.adamaspharma.com/events-presentations and will be available for
replay until February 25, 2019.
About Adamas Pharmaceuticals,
Inc.Adamas’ goal is to create and commercialize a new
generation of medicines intended to lessen the burden of chronic
neurologic diseases on patients, caregivers and society using its
deep understanding of time-dependent biology. The Company is
focused on the commercialization of GOCOVRI® (amantadine) extended
release capsules, the first and only FDA-approved medicine for the
treatment of dyskinesia in patients with Parkinson’s disease
receiving levodopa-based therapy, with or without concomitant
dopaminergic medications. The Company also continues to deliver
differentiated investigational programs, including ADS-5102 in
development for the treatment of walking impairment in patients
with multiple sclerosis. For more information about Adamas and its
unique approach to developing medicines based on time-dependent
biology, please visit www.adamaspharma.com.
Contact
Investors: Peter VozzoManaging Director, Westwicke443-213-0505
peter.vozzo@westwicke.com
Media: Sarah MathiesonVice President, Corporate
Communications510-450-3528smathieson@adamaspharma.com
Adamas Pharmaceuticals (NASDAQ:ADMS)
Historical Stock Chart
From May 2024 to Jun 2024
Adamas Pharmaceuticals (NASDAQ:ADMS)
Historical Stock Chart
From Jun 2023 to Jun 2024